Himalaya Nutravedics India IPO
About Himalaya Nutravedics India Ltd.
Himalaya Nutravedics India Ltd. is engaged in the manufacturing, formulation, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes softgel capsules, tablets, medicated oils, liquid orals, hardgel capsules, and protein powders catering to therapeutic areas such as immunity, digestive health, metabolic wellness, and pain management. The company also undertakes contract manufacturing for third parties and markets its own branded products through healthcare practitioners. Its manufacturing facility is located in Hyderabad, Telangana, and is certified under ISO 9001:2015, ISO 22000:2018, and WHO-GMP standards. The company has a growing presence across multiple Indian states and operates with a focus on both branded and institutional healthcare segments.
Visit WebsiteIPO Details
| Price Band | TBA |
| Face Value | ₹10 |
| Issue Size | TBA |
| Fresh Issue | TBA |
| Total Shares Offered | 25,00,000 |
| Listed On | BSE |
Objects of the Issue
Funding working capital requirements; business development and digital marketing activities; general corporate purposes.
Key Financial Metrics
EPS (Basic)
₹11.72
ROE
63.87%
ROCE
36.41%
Debt / Equity
0.31
Financial Performance
| Particulars (₹ Cr) | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 14.43 | 21 | 43.12 |
| EBITDA | 0.94 | 2.99 | 8.1 |
| PAT | 0.43 | 2.23 | 7.39 |
| Total Assets | 6.09 | 10.82 | 24.42 |
| Net Worth | 1.34 | 6.75 | 16.38 |
| Total Borrowings | 3.24 | 1.76 | 5.13 |
Valuation
Market Capitalisation
P/E Ratio
Promoter Holding
Public Holding
Lot Size & Allocation
Reservation / Allocation
| Category | Allocation | Cut-off |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 50% | Yes |
| NII (Non-Institutional Investors) | 15% | Yes |
| RII (Retail Individual Investors) | 35% | Yes |
Registrar & Lead Managers
Registrar
Lead Managers (1)
Peer Comparison
| Company | Listed | Mkt Cap (₹ Cr) | EPS (₹) | P/E | ROE % |
|---|---|---|---|---|---|
| Himalaya Nutravedics India IPO (this IPO) | — | 95 | ₹11.72 | — | 63.87% |
| The Himalaya Drug Company | No | — | — | — | — |
| Dabur India Ltd | Yes | 95,000 | ₹4.9 | 58.2x | 21.3% |
| Emami Ltd | Yes | 27,000 | ₹16.4 | 28.1x | 24.8% |
| Patanjali Foods Ltd | Yes | 62,000 | ₹42.6 | 45.5x | 19.2% |
| Zydus Wellness Ltd | Yes | 18,000 | ₹29.8 | 52.3x | 12.4% |
| Abbott India Ltd | Yes | 52,000 | ₹220.5 | 48.9x | 35.1% |
Frequently Asked Questions
8 questions about Himalaya Nutravedics India IPO IPO
Community Discussion
Ask questions and share your thoughts about this IPO
Be the first to ask or share about Himalaya Nutravedics India IPO